| 000 | 01751 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513182912.0 | ||
| 264 | 0 | _c19990615 | |
| 008 | 199906s 0 0 eng d | ||
| 022 | _a0022-4804 | ||
| 024 | 7 |
_a10.1006/jsre.1999.5571 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKramer, A A | |
| 245 | 0 | 0 |
_aInduction of tolerance to hemorrhagic or endotoxic shock involves activation of NF-kappaB. _h[electronic resource] |
| 260 |
_bThe Journal of surgical research _cMay 1999 |
||
| 300 |
_a89-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCytosol _xmetabolism |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xmetabolism |
| 650 | 0 | 4 |
_aHemorrhage _xphysiopathology |
| 650 | 0 | 4 | _aI-kappa B Proteins |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 |
_aMacrophages, Peritoneal _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNF-KappaB Inhibitor alpha |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aShock, Hemorrhagic _xphysiopathology |
| 650 | 0 | 4 |
_aShock, Septic _xphysiopathology |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aSurvival |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xgenetics |
| 700 | 1 | _aSalhab, K F | |
| 700 | 1 | _aShafii, A E | |
| 700 | 1 | _aNorman, J | |
| 700 | 1 | _aCarey, L C | |
| 700 | 1 | _aMendez, C | |
| 773 | 0 |
_tThe Journal of surgical research _gvol. 83 _gno. 2 _gp. 89-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/jsre.1999.5571 _zAvailable from publisher's website |
| 999 |
_c10287957 _d10287957 |
||